Novavax Says it is Axing 25% of Its Workforce to Cut Costs
Biotech company Novavax has announced that it will be laying off 25% of its workforce in an effort to reduce expenses. The decision was made to better align the company’s infrastructure and scale with the “endemic Covid opportunity,” according to Novavax CEO John Jacobs. Despite the layoffs, the Maryland-based company is still focused on updating…